drug

REGN9533

1 story · latest Aug 12, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Regeneron Pharmaceuticals

Timeline

Regeneron registers Phase 1b trial of Factor XI/XII antibodies in dialysis patients

Aug 12Trial updateamrecibart cenvacibart

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.